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Abstract: The main functions of biological adhesives and
sealants are to repair injured tissues, reinforce surgical
wounds, or even replace common suturing techniques. In
general surgery, adhesives must match several requirements
taking into account clinical needs, biological effects, and
material features; these requirements can be fulfilled by spe-
cific polymers. Natural or synthetic polymeric materials can
be employed to generate three-dimensional networks that
physically or chemically bind to the target tissues and act as
hemostats, sealants, or adhesives. Among them, fibrin, gela-
tin, dextran, chitosan, cyanoacrylates, polyethylene glycol,
and polyurethanes are the most important components of
these interfaces; various aspects regarding their adhesion
mechanisms, mechanical performance, and resistance to
body fluids should be taken into account to choose the most
suitable formulation for the target application. This review
aims to describe the main adhesives and sealant materials
for general surgery applications developed in the past deca-
des and to highlight the most important aspects for the
development of future formulations. VC 2015 Wiley Periodicals,
Inc. J Biomed Mater Res Part B: Appl Biomater 00B: 000–000, 2015.
Key Words: adhesion, biomimetic, interface(s), polymer,
tissue adhesion
How to cite this article: Scognamiglio F, Travan A, Rustighi I, Tarchi P, Palmisano S, Marsich E, Borgogna M, Donati I, de
Manzini N, Paoletti S. 2015. Adhesive and sealant interfaces for general surgery applications. J Biomed Mater Res Part B
2015:00B:000–000.
INTRODUCTION
Despite sutures are considered a mainstay for several treat-
ments and procedures in general surgery, they also have
some drawbacks mainly associated with high infection rate,
extensive handling, risk of blood-borne disease transmission
and tissue reactivity.1,2 Moreover, the presence of sutures or
staple materials in surgical wounds is considered to
increase the risk of infections, which may retard wound
healing, cause wound chronicity, and also threaten the
patient’s life.3,4 For these reasons, a general trend toward
simpler, quicker, and minimally invasive surgical procedures
has encouraged the development of sutureless techniques
like the use of adhesive and sealant interfaces to restore
soft tissue integrity and functionality. These interfaces can
be successfully employed in the treatment of emergency
hemostasis,2,5 in sealing leaks of gas or ﬂuids,6 and in the
reinforcement of sutures.7 Hemostats work by causing blood
to clot and are indicated to stop nonsuturable or noncauter-
izable bleeding particularly in anticoagulated or coagulo-
pathic patients; several surgical operations require a perfect
hemostasis, so that the principal aim is the reduction of
post-operative bleeding and leakage, especially when paren-
chymal resections or vascular anastomoses are performed.
The use of sealants has been widely described in liver sur-
gery to reduce postoperative blood loss and bile leak,
impacting both short and long-term prognosis as they are
the most detrimental complications in liver surgery.8 Spleen
traumas represent another ﬁeld for the application of seal-
ant interfaces. Laparoscopic spleen-preserving procedures
have been used for patients with hemodinamically stable
splenic injuries; in these patients the topical application of
sealants like ﬁbrin glues has shown to enable good bleeding
control, even in patients lacking clotting factors or platelets
or taking anticlotting medications.9 Sealants can also be
used to prevent the leakage of organic ﬂuids, including
lymph cerebrospinal ﬂuid and gastrointestinal contents.
Anastomotic leakage can occur at all levels of gastrointesti-
nal surgery; recent studies have shown that this risk
appears to be reduced by the use of sealants.10–12 Tissue
approximation of wounds with no tension represents
another ﬁeld in which adhesives can be very useful13; in
these cases the adhesives need to be strong, water resistant
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and able to function as antibacterial barrier. Another com-
mon procedure in general surgery is the use of implantable
biomaterials that should be maintained in situ in close con-
tact with the target tissue; for instance, implanted devices
like meshes, gauzes, webs or catheters need to be kept in
place to properly fulﬁll their functions. Also in these cases,
sutureless techniques offer considerable advantages.14,15
Overall, general surgery requires an increasing use of
adhesive and sealant interfaces for a wide range of opera-
tions and treatments. All these strategies are based on the
concept of bioadhesion, deﬁned as the process whereby syn-
thetic and/or natural macromolecules adhere to a biological
tissue for an extended period of time in the body.16 To cre-
ate stable and safe interfaces, an ideal bioadhesive should
possess several properties. Provided the biocompatibility of
the formulation, which must not be locally irritating, inﬂam-
matory, toxic or antigenic, the adhesive should be easily
applied or injected in a form of liquid or hydrogel on the
target surface. Then, the reticulation process should take
place in the presence of body ﬂuids in a conveniently short
time, according to the requirements of the speciﬁc opera-
tion. After reticulation, the adhesive should be as pliable as
the tissue, in order to follow its physiologic expansion/con-
traction, while at the same time ensuring strong binding
efﬁcacy; for this reason adequate mechanical properties are
required for a proper elasticity/compliance of the interface.
In some cases, the adhesive should progressively undergo
biodegradation after having exerted its function. Finally, one
of the main challenges of bioadhesion is bonding in a wet
physiological environment.16,17
This wide range of functions is pursued by employing
polymers capable of generating a three-dimensional network
that binds to the target tissue. Current surgical adhesive and
sealants are either based on natural compounds or on syn-
thetic materials; the former are generally well accepted by
tissues but often exhibit low adhesive strength while the lat-
ter typically display higher strength but lower biocompatibil-
ity. Depending on the nature of the polymers, the main
classes of adhesives for general surgery include ﬁbrin,18–20
gelatin,21 and formulations based on proteins and polysac-
charides,3,22 cyanoacrylates,23,24 polyurethanes,25,26 and poly-
ethylene glycol (PEG).27,28 Beside polymers, novel adhesive
strategies considering the topography of gecko-foot29 as well
as the use of silica nanoparticle solutions for gluing gels and
tissues are being investigated.30 The reticulation step can fol-
low different routes: it can be triggered by the chemical reac-
tivity of the adhesive compounds or by the interaction with
biological molecules. Chemical approaches include polymer-
ization by contact with physiological ﬂuids (for example, cya-
noacrylates) and reticulation triggered by crosslinkers (for
example, glutaraldehyde or carbodiimide) or by reactive sub-
stituents on the polymer backbone. Biological approaches to
initiate network formation include the enzymatic crosslinking
as in the case of ﬁbrin-based adhesives in which occur the
exploitation of transglutaminase-catalyzed reactions that
occur during blood coagulation.21,31 In general, biochemical
crosslinking approaches are preferred, because they provide
a more biocompatible adhesion strategy.
The effectiveness of a given formulation stems from a
compromise between cohesive and adhesive forces,32 the
former being due to molecular forces within the interface
(bulk-bulk bonding), the latter being due to attractive forces
between the adhesive and the target surface. Cohesive inter-
actions are required only to a certain extent since too much
cohesion may result in a hardened material without signiﬁ-
cant afﬁnity for a surface. However, adhesive interactions
with the target tissue are a fundamental aspect that must
be considered for each speciﬁc organ of the body.
This review is aimed at considering the most important
adhesive and sealant materials for general surgery applica-
tions, thus highlighting the scientiﬁc progress over recent
years and suggesting the importance of continuous research
in this ﬁeld.
ADHESIVES BASED ON NATURAL PRODUCTS
Adhesives based on natural products refer to a class of sub-
stances formulated from bio-based raw materials, which are
employed as adhesives in man-made technology33; some of
these bioadhesives work in wet environment,21,34 which is one
of the most important properties for a surgical adhesive, and
they typically show good biocompatibility.35 However, batch-
to-batch variation may be a serious concern and sometimes it
is difﬁcult to establish reliable large scale production proc-
esses. Most bioadhesives proposed for general surgery are
based on a variety of substances like proteins (for example,
collagen, ﬁbrin, gelatin, and albumin)36,37 and polysaccharides
(for example, chitosan, starch, and dextran).38,39 Protein-based
materials are more commonly used, although polysaccharide-
based systems are gaining increasing attention.
Protein-based adhesives
Proteins such as gelatin, ﬁbrin, and albumin have been used
in general surgery for many years; the main advantage of
protein based formulations is related to their haemostatic
properties that can assist the coagulation process.40,41 They
can also be combined with traditional wound closure meth-
ods such as stitches, grafts or sutures.42,43 The main disad-
vantages of employing proteins as adhesives are their
source, the enzymatic degradability, and the high sensibility
to ﬂuids, as well as the relatively high price. The major com-
ponents of these bioadhesives are directly extracted from
human biological sources, such as blood, or are based on
proteins isolated from animals, such as porcine gelatin or
bovine albumin. Fibrin-based haemostatic adhesives carry a
risk of disease transmission due to the presence of plasma
derived components.44 These adhesives can be used without
the involvement of any other chemical reagents or in combi-
nation with active agents (chemical, enzymatic, or photo-
chemical crosslinkers) that trigger crosslinking reactions of
the glue while simultaneously forming covalent bonds with
the tissue surface.2 The main protein-based adhesives and
sealants are described hereafter.
Fibrin glue. Fibrin-based formulations are currently one of
the main biological sealant systems in general surgery appli-
cations; they are designed to mimic the last stage of blood
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clotting, during which ﬁbrinogen is converted into ﬁbrin
clot through a complex coagulation cascade (Figure 1).45
The process requires the catalysis by thrombin and factor
XIIIa, enzymes belonging to the family of transglutaminases.
Factor XIIIa catalyzes the formation of covalent bonds
between the side chains of different ﬁbrin molecules, con-
tributing to stable crosslinking and resistance to dissolution.
Crosslinking occur through the formation of amide bonds
between glutamine (Gln) and lysine (Lys) residues in
proteins. The transglutaminases have, for this reason, been
classiﬁed as natural biological adhesives.46
Commercial formulations of ﬁbrin glue are typically sup-
plied as a two-component system, in which thrombin (in
combination with a calcium chloride solution) and a concen-
trated solution of human-derived ﬁbrinogen (together with
factor XIII) are placed in separate syringe tubes; the two
components are mixed together prior to the application on
the wounded tissue. In some preparations of ﬁbrin glue, an
antiﬁbrinolytic agent is included, in order to prevent prema-
ture lysis of the clot and to control gelling kinetics.44 The
VivostatVR system (Vivolution A/S Alleroed, Denmark) is an
automated medical device that allows the preparation of an
autologous ﬁbrin sealant starting from patient’s blood.47
This approach enables to eliminate the risk of transmitting
blood-borne diseases, which is one of the major concerns
related to the clinical use of ﬁbrin glues. However, the time
required to produce ﬁbrin this way is approximately two
days; for this reason, the use of autologous ﬁbrinogen is not
compatible with trauma and emergency surgery. All com-
mercial ﬁbrin glues are biodegradable and bioresorbable
and the degradation of the ﬁbrin clots occurs through
thrombolysis in a time that ranges from few days to weeks.
The properties of commercial ﬁbrin glues can be modulated
by varying their composition48: in a typical formulation the
ﬁbrinogen concentration is higher than the one in human
plasma, which positively contributes to the strength of the
ﬁbrin glue, while thrombin concentration determines the
curing time to achieve maximum adhesive strength.49 The
use of ﬁbrin glue hastened when the ability of producing
highly concentrated ﬁbrinogen was developed, accounting
for stronger adhesion properties.50 The main physical and
chemical processes used for obtaining the ﬁbrinogen neces-
sary to prepare ﬁbrin glues and sealants are based on
cryoprecipitation and precipitation with ammonium sulfate,
ethanol or PEG. Cryoprecipitation involves several cycles of
freezing/thawing and although being a time consuming pro-
cess, it presents the advantage of avoiding the addition of
exogenous chemicals51,52; however, this method enables to
obtain low concentrations of ﬁbrinogen, which reduces the
effectiveness of the adhesive formulation. Conversely, chemi-
cal precipitation is considered a fast and efﬁcient method to
obtain high ﬁbrinogen concentrations, but with insufﬁcient
purity.53 Fibrin-based adhesives are clinically used in gen-
eral surgery mainly as hemostats, primary wound closure
agents, and as adjuncts to sutures and staples. The majority
of reported applications are in surgical procedures, to con-
trol bleeding and leaking during and after surgery.18–20
Fibrin glue is also used as hemostatic agent and sealant in
vascular surgeries, particularly to prevent bleeding from
suture line and graft area, which is a common issue in this
type of operations.54–56 The application of ﬁbrin glues in
the treatment of gastrointestinal diseases, such as in
patients suffering from bleeding peptic ulcers, has also been
investigated with the aim of replacing surgical procedures
by noninvasive endoscopic injections.57 The main disadvan-
tages of these adhesives are the poor mechanical strength
and adhesion in wet environment and the concerns related
to the safety of the products. The main concern regards
viral transmission (such as HIV, parvovirus B19, hepatitis B,
or hepatitis C) from formulations prepared using pooled
blood.2 Only in 1998, the FDA approved the product
TisseelVR (Baxter Healthcare, Deerﬁeld, IL), the ﬁrst genera-
tion of commercial ﬁbrin glues. However, some adverse
responses can be associated to the use of ﬁbrin-based adhe-
sives. For instance, allergic skin responses58 or anaphylactic
reactions59 were reported in patients who have been
exposed to the bovine aprotinin contained in ﬁbrin sealant.
Recently, the efﬁcacy of ﬁbrin sealants was tested in a clini-
cal trial: patients undergoing laparoscopic Roux-en-Y gastric
bypass were treated with human ﬁbrin sealant and a reduc-
tion of the postoperative bleeding was observed.37
Gelatin based adhesives. Gelatin is an irreversibly hydro-
lyzed form of collagen with many industrial, pharmaceutical,
and biomedical applications. Gelatin has been used for cen-
turies as an adhesive for technical applications and was
among the ﬁrst polymeric components to be adapted for
medical adhesives. Gelatins are cheap, biocompatible and
FIGURE 1. Formation of clot based on fibrin crosslinking.
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bioresorbable materials that can form strong, transparent,
and ﬂexible gels and ﬁlms, granting them suitable proper-
ties for internal surgery. Gelatin-based tissue adhesives have
been recently proposed in clinical ﬁeld for the treatment of
aortic dissection: the amino groups of gelatin were modiﬁed
with cholesteryl residues conferring improved properties to
the adhesive in terms of bonding strength and tissue pene-
tration.60 Because gelatin hydrogels are relatively unstable
in aqueous solutions (they swell and typically dissolve
above 35 C), various chemical crosslinking methods have
been used to confer stability under biological conditions to
meet bioadhesive properties. The primary purpose of the
chemical modiﬁcation of gelatin with a crosslinker is to
increase its adhesion strength and control its degradation
rate; crosslinking can be achieved through chemical, photo-
chemical, and enzymatic approaches, as described in the
next sections.
Chemically crosslinked gelatin (gelatin-resorcinol-
formaldehyde, GRF glue). In these formulations, gelatin
chains are crosslinked by aldehydes through a polyconden-
sation reaction. Simultaneously, gelatin amine groups react
with amine groups of tissue proteins to form a covalent
bond with it (Figure 2); in addition, resorcinol molecules
are reticulated by means of formaldehyde to yield a three-
dimensional network.2
The curing proﬁle of GRF adhesives can be altered by
adjusting the ratio of the components; these adhesives are
capable to bind to wet tissues and form covalent linkages
with functional groups on the tissue surface. Bonding
strength is ensured by the penetration of the components
into the tissue. Nevertheless, its performance is limited by
the cytotoxicity associated with formaldehyde.61 Resorcinol is
less toxic than other phenols because it is less oxidized and
produces lower levels of oxygen radicals.62 Some researchers
FIGURE 2. Crosslinking of gelatin with aldehydes and resorcinol (Reproduced from Ref. 2).
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argued that the GRF glue may become innocuous if an
optimal composition of the components can accomplish a
polymerization with no residual formaldehyde.61 There is
substantial evidence that GRF glue has beneﬁcial effects on
perioperative bleeding and on the incidence of reopera-
tion.63,64 Surgical application of GRF glues is recommended
in cases in which tissue integrity is poor, hemostasis is chal-
lenging, and high bonding strength is absolutely imperative.
Enzymatically crosslinked gelatin (gelatin-mTG
adhesive). Gelatin can be used as a sealant in combination
with a microbial transglutaminase (mTG),34 which is capa-
ble to catalyze its crosslinking.21,65,66 mTG catalyzes the for-
mation of a covalent bond between a free amine group of a
peptide-bound Lys and the acyl group at the end of the side
chain of a peptide-bound Gln, with the production of a mol-
ecule of ammonia (Figure 3).
The safety of mTG for medical applications has not been
extensively tested, but it is worthwhile to note that this
enzyme is approved for food uses. Both gelatin and mTG
are commercial products obtained from sources that raise
less concern than blood. The mTG-catalyzed crosslinking of
gelatin does not require low MW compounds (that is, mono-
mers, initiators, and crosslinkers) prior functionalization of
the polymer backbone, nor photopolymerization. The cur-
rent in vitro evidence indicates that the gelatin–mTG adhe-
sive is effective under wet conditions21,34 and that this
adhesive confers strengths comparable to other soft-tissue
adhesives like ﬁbrin based sealants.34 The resulting cross-
linked network resorbs as a result of normal proteolytic
processes. Viscosity and elasticity of the glue (but not its
adhesive strength) depend on gelatin type and concentra-
tion.67 One limitation of the gelatin-mTG adhesive is that
the protein forms a physical gel at room temperature, and it
needs therefore to be warmed to 37 C prior to use, which
could be inconvenient for surgical techniques. Additional
long-term studies are required to ensure the biocompatibil-
ity and biodegradability of this adhesive and to assess the
potential of the gelatin-mTG adhesives to promote wound
healing process.
Photocrosslinked gelatin. The synthesis of a tissue sealant
based on a photocrosslinkable gelatin was recently reported
and the formulation showed high elasticity while retaining
excellent adhesive strength.68 In this case, self-associating
proteins, for example, resilin and ﬁbrinogen, can be cova-
lently crosslinked via di-tyrosine bonds within seconds
using visible light.68 Elvin et al. proved that naturally self-
associating proteins that contain surface accessible Tyr resi-
dues can be crosslinked into polymers using the ruthenium-
based photochemistry.69 The main drawback of the photo-
polymerized gelatin is its high swelling ratio (over 240%
within 24 h); in an attempt to reduce this swelling, gelatin
was derivatized with phenolic residues to increase its
amount of tyrosine residues.68
The potential of photocurable gelatin in tissue sealing was
tested in a sheep surgical model68: the photopolymerized gel-
atin sealed a wound in lung from leakage of blood and air,
with excellent post-surgery outcomes. In another study, a pho-
tochemically crosslinked gelatin sealant was used in rabbit
and canine gastrointestinal models with good mechanical and
biological outcomes; the sealant demonstrated high elasticity
and adhesive strength and good tissue integration.70
The effectiveness of a gelatin-based adhesive was eval-
uated in an experimental study on rat’s liver: the results
pointed out its efﬁcacy in the establishment of a good tissue
adhesion and hemostasis.71 Sato et al. reported a case where
the use of gelatin-resorcinol-formal glue was effective in the
treatment of postoperative ﬁstula following a low anterior
resection in colorectal surgery.72 Despite all the advantages
of this material, potential contamination with animal infective
agents is still the major concern on the use of gelatin.
Albumin-based glues. Albumin–glutaraldehyde adhesives
are able to establish covalent bonds with functional groups
on the tissue surface, thus creating an elastic seal. These
glues also adhere to synthetic graft materials through
mechanical bonding within the interstices of the graft
matrix. The reticulation of bovine serum albumin (BSA)/
glutaraldehyde tissue adhesives occurs by a condensation
reaction between amino groups of Lys residues in the BSA
protein and glutaraldehyde. Albumin–glutaraldehyde glues
tend to degrade slowly and they can persist at the repair
site for up to 2 years after application.73 The commercial
formulation BioGlueVR (Cryolife, Kennesaw, GA) is a tissue
adhesive composed of BSA mixed with glutaraldehyde and
is able to adhere to tissues and to synthetic graft materials.
It is currently being used as an adjunct for securing hemo-
stasis at vascular anastomoses.74,75 The effectiveness of Bio-
GlueVR in preventing air leakage in pulmonary surgery was
demonstrated on rats.76 In a pilot clinical study, the useful-
ness of BioGlueVR for the treatment of high transsphincter
anal ﬁstulas was reported.36 An improper use of albumin–
glutaraldehyde glues was reported to cause negative out-
comes in case of excessive application.77 An in vivo study on
rabbits reported that the release of glutaraldehyde upon
polymerization could cause a certain extent of cytotoxicity
when applied on lung and liver tissue.74
FIGURE 3. Crosslinking of Gln and Lys residues of gelatin by mTG. (Reproduced from Ref. 21).
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Polysaccharide-based adhesives
In nature, polysaccharides and proteins (or a combination of
the two) are natural mediators of adhesion and have found
many industrial and pharmaceutical applications over the
past decades. They represent a very attractive class of biomo-
lecules for various biomedical ﬁelds, including general sur-
gery. In this ﬁeld, two polysaccharides from marine source,
alginate and chitosan, are particularly attractive owing to
their biocompatibility, hydrophilicity, adhesiveness, and hemo-
static activities.78,79 These two polysaccharides have been
used for the preparation of adhesive nanosheets.80 As to
polysaccharide adhesivity, it should also be mentioned that
some microorganisms use acidic or neutral exopolysacchar-
ides (that is, dextran, heparan sulfate, levan) to adhere to a
variety of substrates.81 Certain polysaccharides are able to
form hydrogels that exhibit high swelling ratios; although
this is a desirable feature when polysaccharides are used in
modern wound dressing formulations, in general surgery pro-
cedures excessive swelling of polysaccharide-based adhesives
can affect the compliance to the tissue. To reduce such
behavior and to enhance adhesivity, these polysaccharides
can be subjected to chemical modiﬁcations as described in
detail in the following paragraphs.
Dextran-based adhesives. Dextran is an exocellular bacte-
rial polysaccharide predominantly consisting of linear a-1,6-
linked glucopyranose units, with some degree of 1,3-branch-
ing. This highly water-soluble polymer is produced in a
sucrose-rich environment by Lactobacillus, Leuconostoc, and
Streptococcus and is commercially available with different
molecular weights. Dextran is also nontoxic and biocompati-
ble and can be degraded through the action of different
dextranases (a-1,6 -glucosidases) in various organs in the
human body, including liver, spleen, kidney, and colon82,83;
both the degree of branching and the molecular weight dis-
tribution affect its physicochemical properties.84,85 Besides
being highly water-soluble, dextrans are stable under mild
acidic and basic conditions. Furthermore, these polymers
contain a high density of hydroxyl groups, making them
suitable for derivatization and subsequent chemical or phys-
ical crosslinking.85 Dextran-based hydrogels can be used as
surgical adhesives; for this application, reactive groups (for
example, aldehydes) are introduced into the polymer
chain.38,86 The introduction of these groups can be accom-
plished by selective oxidation with periodic acid or period-
ate salts which causes the formation of a dialdehyde-
dextran compound, with a free hydroxyl group next to the
newly formed aldehydes (Figure 4).
Polysaccharides that have acquired aldehyde groups as a
result of oxidation can react with amine groups of cell sur-
face proteins of the tissues thus allowing bioadhesion.87,88
Moreover, oxidized dextrans can react with amino groups of
additional components like gelatins or aminated PEGs to
form intermolecular crosslinks.87 Recently, dextran-PEGs
bioadhesives have been proposed as soft tissues sealants39;
the cohesive integrity of dextran-PEGs formulations comes
from imine bonds that form through a Schiff base reaction
between amines and aldehydes (Figure 5).89 The cohesive
properties depend on the chemical structure of PEG (for
example, number of arms), while tissue/material adhesion
strength is primarily determined by the number of alde-
hydes in the oxidized dextran.
Recently a hydrogel tissue adhesive, obtained by reacting
an oxidized dextran with a water-dispersable multiarm poly-
ether amine (PEG) has been developed (ActaMaxVR ): the
crosslinking reaction occurs in water and the components
undergo a Schiff base reaction to form a crosslinked hydro-
gel that reticulates within 1 min at room temperature. The
formed adhesive is able to adhere to moist tissue and it
degrades hydrolytically.90 Dextran-PEGs adhesives were
shown to be non-cytotoxic and noninﬂammatory, they do
not pose the risk of viral contamination90 and have been
used in sealing small intestinal puncture.39 In a recent
experimental study, Artzi et al. applied this adhesive on a
small bowel rat model: the average adhesion force to intes-
tinal tissue was found to be higher than with ﬁbrin sealant
and close to cyanoacrylates.89
Chitosan-based adhesives. Chitosan is a linear polysaccha-
ride composed of randomly distributed b-(1-4)-linked D-glu-
cosamine residues with a variable number of randomly
located N-acetyl-D-glucosamine units; it is produced by
deacetylation of chitin, the structural component of the exo-
skeleton of crustaceans. This polysaccharide has drawn a lot
FIGURE 4. Oxidation of dextran to yield reactive dextran aldehyde for adhesive formulations.
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of attention in the biomedical ﬁeld, because of its biocom-
patibility, antioxidant, and bacteriostatic properties.91,92
Chemical modiﬁcations of its amino and hydroxyl groups
provides a powerful mean to tailor its biological activity and
to modify its physico-chemical properties. Owing to its basic
nature, it has the ability to interact with anionic biopoly-
mers, such as glycosaminoglycans, heparin, proteoglycans,
and nucleic acids. This ability represents an important
aspect in the development of soft tissues bioadhesives. How-
ever, despite pure chitosan solutions can establish molecular
interactions with the target tissue, they lack cohesion and
are not able to generate sufﬁcient adhesion. Cohesion and
adhesion can be increased by following various crosslinking
strategies. Chitosan-based adhesives prepared through pho-
tochemical crosslinking reactions possess photoreactive
inert groups (generally phenyl azides and diazirines) that
become reactive when exposed to ultraviolet or visible
light. A photocrosslinkable hydrogel based on chitosan,
4-azidobenzoic acid (Az)-chitosanVR has been proposed for
peripheral nerve anastomosis93; this bioadhesive was syn-
thesized by conjugating Az with low and high molecular
weight chitosans. Another commercially available chitosan-
based product is SurgiLuxVR : the laser activation strengthens
the adhesion of the formulation to tissue collagen through
polymer chain interactions as a consequence of transient
thermal expansion.94 Its experimental use on intestinal
tissue demonstrated good biocompatibility and negligible
thermal damage as a consequence of irradiation.35 Another
crosslinking strategy was followed by Serrero and
coworkers who reported the preparation of a hydrogel by
adding a multifunctional crosslinker based on oxidized
starch to chitosan95; owing to the aldehyde groups of the
oxidized starch, adhesion can be achieved by the molecular
interaction with collagen amine groups or with other pro-
teins within the tissue.87 Various physico-chemical parame-
ters (chitosan concentration, molecular weight, degree of
starch oxidation) were found to inﬂuence the adhesion
properties of the formulations; adhesion tests demonstrated
that low molecular weight chitosans were more effective
than high molecular weight ones. This behavior was
ascribed to improved mobility of the former macromole-
cules, which likely promotes a wider interaction surface
with the tissue, hence an easier covalent or physical bond-
ing with the biological substrate. However, no data about
the biocompatibility of the system are available.
Synthetic adhesives. Performance limitations, safety con-
cerns, and potential risks associated with the use of some
natural-based adhesives (mostly proteins) have driven
researchers to develop adhesives based on synthetic poly-
mers. Synthetic adhesives are based on synthetic chemicals
typically in the form of monomers, prepolymers, or noncros-
slinked polymers, which undergo polymerization or cross-
linking to form an insoluble adhesive matrix when delivered
on a tissue.2 Their three-dimensional structure as well as
their chemical composition can be controlled to expose
functional groups that can interact with biological tissues,
thus providing bioadhesion.28,96 Molecular weight of nonbio-
degradable synthetic polymers should be under the thresh-
old of renal excretion since these polymers have to be
cleared by the kidneys.97 In general, synthetic tissue-
adhesives are not associated with the risk of infectious con-
taminations, although their biocompatibility and toxicity
may represent an issue especially in the case of highly reac-
tive components. Several synthetic adhesive materials are
employed for general surgery applications: according to
their chemistry, the main formulations are based on cyanoa-
crylates, PEG, and polyurethanes.
Cyanoacrylate adhesives. Cyanoacrylate tissue adhesives
are currently the main synthetic polymeric sealants in clini-
cal usage; they possess high bonding strength, very rapid
setting time, and instantaneous adhesion to tissues. Some
formulations are also reported to inhibit the growth of bac-
teria.98 They are prepared as a single-component system
that polymerizes at room temperature without the addition
of a catalyst, solvent evaporation, heat, or pressure applica-
tion. These adhesives require no external initiation for
FIGURE 5. Dextran-PEG adhesive: the oxidized dextran aldehyde reacts with an aminated PEG to form a crosslinked hydrogel network through
imine bond formation. (Reproduced from Ref. 89).
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curing: cyanoacrylates can rely on small amounts of water
to initiate the polymerization reaction and bonding occurs
within seconds.
The basic cyanoacrylate monomer (alkyl-2-cyanoacrylate)
is a low-viscosity liquid and is formed by combining formal-
dehyde and alkyl-2-cyanoacetate (Figure 6). The most com-
mon polymerization initiators for cyanoacrylates are the
hydroxyl ions within water. Upon contact with wet tissues
(such as skin, moisture, or blood), cyanoacrylates polymerize
into a solid ﬁlm that binds juxtaposed wound edges. Adhe-
sion is achieved through two independent mechanisms:
(i) molecular interaction via covalent bonding to proteins
exposed on tissue surface and (ii) penetration of cyanoacry-
late monomers into cracks and channels in the tissue surface
(mechanical interlocking). For these reasons, cyanoacrylate
adhesives are particularly effective on moist and porous
substrates.99,100
In Figure 6, the general chemical structure and polymer-
ization reaction of the cyanoacrylate adhesives is illustrated.
The alkyl or carbon side chain AR has an important effect
on the strength and physical properties of the glue. In com-
parison with complex, long-chain derivatives, straight, and
short-chain monomers (AR5ACH3 or AC2H5) form tighter
and stronger bonds, which results in more rigid and brittle
interfaces.101 In contrast, by increasing the length or com-
plexity of side alkyl group, the polymerization rate tends to
decrease and interfaces with more ﬂexibility are formed.
Cyanoacrylate-based adhesives may also contain plasticizers,
dyestuffs, thickeners, polymerization catalysts, anionic and
radical stabilizers and other additives to make the formula-
tion easier to handle and biologically safer. In the human
body, cyanoacrylate adhesives undergo hydrolytic degrada-
tion, which takes place through nonenzymatic routes; the
main degradation products are formaldehyde and the corre-
sponding alkyl cyanoacetate. The degradation rate of cya-
noacrylate polymers decreases with longer alkyl side chain,
as a result of steric hindrance102; therefore short-chain
derivatives degrade very quickly, resulting in a higher
amount or local concentration of breakdown products,
which are potentially harmful to cells and tissues and may
cause inﬂammatory reactions and impair wound healing.
High-molecular-weight polymers with longer side chain
degrade slowly, which translates into producing less toxic
degradation products; however, their persistence in the
body may cause medical complications.103 Although all cya-
noacrylates arise from the same basic structure, subtle var-
iations can dramatically change the properties of the
compounds (ﬂexibility, setting time, bond strength, viscosity,
heat of polymerization reaction, biocompatibility, toxicity,
and degradation proﬁle). Cyanoacrylates have proven to be
valuable in sutureless surgery: in many cases, wound clo-
sure can be safer, stronger, and more functional than with
traditional suturing (that is, titches).104 The development
and clinical evaluation of these materials for general surgery
was delayed because of safety issues; however, in the last
decade a lot of efforts were devoted to cyanoacrylate appli-
cations other than cutaneous. An important use of cyanoa-
crylate formulations is for hemostatic purpose105 like in
anastomotic connections where there is a high risk of bleed-
ing complication.106,107 Cyanoacrylates possess several
advantages for tissue approximation and their applications
include wound closure or small Pfannenstiel incisional cuts
performed during clean abdominal surgery.13 To reduce
possible inﬂammatory reactions and confer the desired
adhesive strength and ﬂexibility, novel cyanoacrylate-based
formulations include additional components; as an example,
the commercial formulation Glubran2VR is a mixture of n-
butyl-2-cyanoacrylate (monomer) and methacryloxysulpho-
lane (monomer) and it displays anti-inﬂammatory proper-
ties.108 Glubran2VR has been tested for mesh ﬁxation in
Lichtenstein’s inguinal hernia repair, with positive outcomes
compared to traditional suturing methods.109 In a recent
FIGURE 6. Cyanoacrylate chemistry: (A) Synthesis of alkyl-2-cyanoacrylate monomer and (B) polymerization reaction.
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study, liver retraction was successfully achieved using n-
butyl-2-cyanoacrylate glue in single-incision laparoscopic
upper abdominal surgery.110 A commercial 2-octyl cyanoa-
crylate (Dermabond AdvancedTM, Ethicon, Johnson, and
Johnson Medical) was shown to reduce the rate of postoper-
ative pancreatic ﬁstula after pancreaticoduodenectomy.111
The use of cyanoacrylate in surgical anastomosis for general
surgery has been proposed as an alternative to microsur-
gery particularly in centers where facilities are unavailable
and the ﬁnancial implication is unbearable for the
patient.106
PEG–BASED ADHESIVES AND SEALANTS
PEG is a neutral, biocompatible, and hydrophilic polymer
widely employed in the biomedical ﬁeld. It is soluble in
aqueous solutions, which makes it a good candidate for
hydrophilic and biodegradable systems. PEGs are pre-
pared by polymerization of ethylene oxide and are com-
mercially available over a wide range of molecular
weights and with a variety of end groups. Since it is not
able to establish a bioactive interaction with biological
matter, tissue adhesives based on PEG are prepared by
grafting reactive moieties capable to establish covalent
bonds with tissues; the resulting hydrogels can be
employed as sealants for wound closure and as suture
adjuvants to help hemostasis in the wounded site. For
instance, Lee et al. described the preparation of PEG-
based hydrogels modiﬁed through the coupling with L-3,4-
dihydroxyphenylalanine endgroups conferring enhanced
mucoadhesivity to the resulting hydrogels.28 PEG-based
adhesives are designed to provide a seal through covalent
bonding to tissue surfaces while retaining ﬂexibility and
allowing a normal physiological dilation without stiffen-
ing, thus limiting mechanical stress.112 PEG-based tissue
adhesives are degraded through hydrolysis; they typically
have a high swelling ratio and display a rapid degradation
proﬁle, which may represent a drawback for long-term
wound reinforcement.20
FIGURE 7. Formation of a 3D network by reaction of star-shaped PEG polymers in CosealVR PEG-PEG sealant: reticulation occurs by formation of
thioester bonds and release of N-hydroxysuccinimide. (Reproduced from Ref. 49).
FIGURE 8. Tissue adhesion mechanism of urethane-based adhesive: H2N-R
0 represent tissue amines that react with isocyanate groups through
urea bond formation.
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TABLE 1. Summary Table of Adhesive and Sealant Classes of Materials for General Surgery Applications
Adhesive/
Sealant Class Main Applications Curing Mechanism Pros Cons Ref.
Fibrin Hemostatic agents
in adjunct to
common
suturing
techniques
Enzymatic
crosslinking
Hemostasis
possibilility to
modulate
adhesive prop-
erties by varing
the composition
Poor adhesion in
wet environ-
ment possible
viral transmis-
sion and
adverse
response
(4,18–20,30,35
39–41,43,44)
Gelatin Gluing of
biological
tissues
Chemical,
enzymatic or
photochemical
crosslinking
Possibility to mod-
ulate the com-
position to
prevent the for-
mation of alde-
hydes binding
in moist condi-
tions biocom-
patibility and
biodegradability
Presence of
aldehydes high
swelling ratio
(4,21,46,50–52,54,55)
Albumin Hemostatic agents
for cardiovascu-
lar anastomosis
Chemical
crosslinking
Effective seal of
vascular anasto-
mosis adhesion
to synthetic
graft material
Slow degradation
rates possible
adverse
reactions
associated to
glutaraldehydes
(59–61)
Dextran Use as surgical
adhesives and
soft tissue
sealants
Chemical
crosslinking
Good adhesion in
moist environ-
ment possibility
to introduce
chemical and
physical
crosslinking
Presence of
aldehydes
(71–73,76,78)
Chitosan Wound healing
treatment and
soft tissue repair
Photochemical
crosslinking
Antimicrobial
properties
possibility to
tailor physico-
chemical
properties by
chemical
modifications
Possible tissue
damage upon
thermal
irradiation
(79–84)
Cyanoacrylate Hemostasis, wound
closure in suture-
less surgery
Chemical
crosslinking
Effective on moist
and porous
substrates high
bonding
strength possi-
bility to modu-
late bonding
strength, viscos-
ity, and degra-
dation profiles
Possible formation
of poorly
biocompatible
degradation
products
(13,85–92)
PEG Suture and graft
adjuvant,
hemostatic agent
Chemical or
photochemical
crosslinking
Possibility to tailor
physico-
chemical prop-
erties of PEGs
hydrophilicity
and flexibility of
hydrogels
High swelling ratio
rapid degrada-
tion profile
(20, 26,76,91,100)
Polyurethane
(PU)
Reduction of
spaces where
fluids can
accumulate
(abdominoplasty)
Chemical
crosslinking
Good wettability
possibility to tai-
lor physico-
chemical prop-
erties of PUs
Long setting time
possible forma-
tion of poorly
biocompatible
degradation
products
(4,24,25)
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The commercial formulation CosealVR (Cohesion Technol-
ogies, Deerﬁeld, IL) is composed of two types of four-arm
PEGs (with a pentaerythritol core), one of which bears a
glutaryl-succinimidyl ester as the terminal group while the
other is capped with thiolic functions2; when the solutions
of these two PEGs combine, the polymers begin to crosslink
and form a network through the reaction of thiol groups
with the carbonyl groups of the succinimidyl ester, resulting
in the formation of a covalent thioester bond between the
two multiarm PEG molecules and by the release of N-
hydroxysuccinimide (Figure 7).113
The functionalized PEG end groups additionally react
with functional groups (particularly amine groups) of the
proteinaceous matrix to form covalent bonds, providing a
chemical linkage between the PEG–PEG hydrogel and the sur-
rounding tissue.96 This formulation is proposed as a resorb-
able sealant for suture lines to prevent leaks.27 CosealVR was
tested for the reinforcement of intestinal anastomoses,
although its use did not show a signiﬁcant increase of burst-
ing resistance.114 In a similar study, a crosslinked hydrogels
based on PEG and dextran aldehyde polymers was studied
for the repair of intestinal wounds; this adhesive formulation
exhibited considerable viscoelasticity and enabled to increase
burst pressure.39 In an experimental study on porcine model,
a PEG-collagen hydrogel was applied to a pancreatic injury to
prevent a pancreatic leak; the results showed that the PEG-
based sealant could prevent a ductal leak following pancre-
atic injury.115
POLYURETHANE-BASED ADHESIVES (PU)
Polyurethanes are a family of polymers composed of two
main components: isocyanates (containing two or more iso-
cyanate groups per molecule) and polyols (containing on
average two or more hydroxyl groups per molecule), which
typically react in the presence of catalysts and a variety of
other additives (such as chain extenders, crosslinkers and
surfactants).2 The properties of polyurethane are greatly
inﬂuenced by the types of isocyanates and polyols
employed. The wide variety of components and processing
conditions, allow to tailor the adhesive formulations for the
designed use.116 The basis of polyurethane chemistry is the
high reactivity of isocyanates, which can be assigned to the
positive charge of the carbon atom in the cumulated double
bond system of its N@C@O group. Urethane-based adhe-
sives typically consist of isocyanate-terminated prepolymers
that form a polymer network reacting with water molecules
upon contact with biological environment.2 These prepoly-
mers covalently adhere to tissue through formation of urea
bond between available isocyanate groups and amines of
tissue proteins,117 as shown in Figure 8.
Isocyanate-terminated pre-polymers usually exhibit long
setting time (in the order of tens of minutes) when no cata-
lyst is used, which limits their use as tissue adhesives.2 To
address the issues of long setting time and potential toxicity
of degradation products, researchers incorporated new com-
pounds in polyurethane synthesis: linear and multiarm pre-
polymers capped with more reactive and less harmful
isocyanate groups are now widely used.118 Urethane-based
polymers display good properties as bioadhesives since they
possess good wettability and capability to establish covalent
interactions with body tissues. Recently, a Lys-derived ure-
thane adhesive, TissuGluVR (Cohera Medical), was developed
for large ﬂap surgeries such as abdominoplasty. This glue is
described as resorbable and nontoxic; it forms a strong
bond between tissue layers and it eliminates or reduces
ﬂuid accumulation and the need for postsurgical drains.
TissuGluVR was used on patients undergoing abdominoplas-
tic surgery and the results showed that, in comparison to
standard surgical closure techniques, it effectively binds tis-
sue layers together, thereby reducing dead spaces where
seroma can occur, while it also reduces post-surgery wound
drainage.26 More recently, a long term evaluation of
TissuGluVR showed that it is capable of preventing the for-
mation of seroma in a canine abdominoplasty model.25
To conclude, the main features of the adhesive and seal-
ant interfaces for general surgery applications discussed in
this review are summarized in Table 1.
CONCLUSIONS
In the ﬁeld of general surgery, several clinical needs are
being addressed by the use of adhesive and sealant interfa-
ces; their use offers numerous advantages and it can be
extended to further clinical situations that would beneﬁt
from the employment of sutureless techniques. Both syn-
thetic and natural-based polymers are successfully being
studied and employed and each adhesive class brings sev-
eral advantages, although limitations related to the material
features should always be considered.
Synthetic polymers offer several advantages especially in
terms of mechanical performance but they can have limita-
tions like poor biocompatibility and excessive stiffness;
However, natural-based polymers typically form weaker
interfaces but they are more similar to the macromolecular
features of human tissues. When designing a new adhesive,
the formulation has to be tailored for the speciﬁc target tis-
sue, which means that since the early stages of its develop-
ment, it must be conceived considering its clinical use.
Hence, it is the medical application of the adhesive that dic-
tates its features. This point should be taken into account
when employing commercial adhesives for applications that
were not designed for and it highlights that no universal
solution has been developed so far in this ﬁeld, given the
wide morphological and functional heterogeneity of body
tissues.
In the future, hybrid materials exploiting in a synergic
manner the advantages of both synthetic and natural com-
pounds will gain increasing importance. Within this chal-
lenge, bioinspired adhesive strategies that take inspiration
from nature are expected to bring further impulse to this
ﬁeld of research toward novel solutions.
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